Related Articles
The immune landscape of hepatocellular carcinoma‑where we are? (Review)
Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (Review)
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
The tumor microenvironment in hepatocellular carcinoma (Review)